雅胆子乳治疗原发性肝癌38例临床效果观察

CLINICAL RESEARCH 0N THE CARRIER OF TAVA BRUCEA MILK UNDER THE GUIDING TREATMENT TO 38 CASES OF THE PRIMARY CANCER OF LIVER

  • 摘要: 为了探讨中药鸦胆子乳在原发性肝癌导向治疗中的多功能载体作用,我院从1993年1月~1996年10月采用鸦胆子乳乳化碘油(A组)和单纯碘油(B组)为载体,对38例患者进行80多次的临床对照研究.三年生存期A组为12%,B组为0,结果表明A组的疗效明显高于B组。分析鸦胆子乳载体作用、栓塞及化疗作用,证明鸦胆子乳是一种有发展前途的多功能载体,且使用方便、经济、副作用少,可以在临床上广泛使用。

     

    Abstract: To go further int0 the carrier function in many ways, we used the emulsified iodine oilby tava brucea milk as a carrier to treat the patients (Group A ) and also the pure iodine oil as a carrier(Group B). By studying 38 patients carefully for more than 80 times in clinic, we found l2 percent of thepatients ln group A was able to live for 3 years, but no 0ne lived f0r 3 years in group B. It was obvious thatthe curative effect of group A was better than that of group B. When analysing the carrier function, embolism and chemical treatment, we find tava brucea milk is a kind of promising carrier of many functi0ns.What's m0re, it can be used easily and has little side effect and costs little.

     

/

返回文章
返回